Syntec Optics Holdings, Inc.
OPTX Nasdaq Optical Instruments & Lenses Financials FY2022βFY2025
What Syntec Optics Holdings, Inc. does
No business description yet.
- Legal name
- SYNTEC OPTICS HOLDINGS, INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 31, 2026
- Accession Β· CIK
- 0001493152-26-014180
0001866816
Revenue and margins
Syntec Optics Holdings, Inc. had $28.1M of revenue in fiscal 2025, down 1.3% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $0.0M in fiscal 2025, 0.1% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Syntec Optics Holdings, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 0.6%.
Balance sheet
Cash, debt and the ratios that show how comfortably Syntec Optics Holdings, Inc. can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Cash and short-term investments | $0.1M | $2.2M | $0.6M | $0.4M |
| Debt incl. finance leases | $3.5M | $2.4M | $3.1M | $4.4M |
| Net debt / EBITDA | 1.3x | 0.1x | 13.1x | 1.9x |
| Debt / equity | 0.4x | 0.2x | 0.3x | 0.3x |
| Current ratio | 1.1x | 1.3x | 1.3x | 1.3x |
| Quick ratio | 0.8x | 0.8x | 0.7x | 0.6x |
| Total assets | $22.5M | $26.5M | $26.0M | $24.3M |
| Total liabilities | $13.0M | $13.5M | $15.0M | $14.8M |
| Shareholders' equity | $9.5M | $13.1M | $11.0M | $9.5M |
| Net debt (β = net cash) | $3.4M | $0.2M | $2.5M | $4.0M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Net income is positive | β | β | β | β |
| Cash from operations is positive | β | β | β | β |
| Return on assets rose | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β |
| Debt fell relative to assets | β | β | β | β |
| Current ratio rose | β | β | β | β |
| Share count didn't rise | β | β | β | β |
| Gross margin rose | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β |
| F-score | β / 3 | 7 / 9 | 1 / 9 | 7 / 9 |
| Accruals ratio | β10.5% | β3.3% | β5.8% | β9.8% |
| Altman Z'' | 2.33 | 3.71 | 2.03 | 2.51 |
4 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $27.8M | $29.4M | $28.4M | $28.1M |
| Gross profit | $6.1M | $7.9M | $5.7M | $6.5M |
| Research and development | β | β | $1.0M | $0.6M |
| Operating income | β$0.5M | $1.5M | β$2.6M | β$0.5M |
| Pretax income | β$0.6M | $1.3M | β$3.0M | β$1.4M |
| Income tax | β$0.2M | β$0.7M | β$0.5M | $0.4M |
| Net income | β$0.4M | $2.0M | β$2.5M | β$1.8M |
| Diluted EPS | β$0.01 | $0.06 | β$0.07 | β$0.05 |
| Diluted shares | 0.03B | 0.03B | 0.04B | 0.04B |
| Cash flow | ||||
| Cash from operations | $1.9M | $2.8M | β$0.9M | $0.7M |
| Capital expenditure | $1.2M | $1.9M | $1.2M | $0.6M |
| Free cash flow | $0.7M | $0.9M | β$2.2M | $0.0M |
| Depreciation and amortization | $3.1M | $2.8M | $2.8M | $2.6M |
| Stock-based compensation | β | β | $0.5M | $0.3M |
| Balance sheet | ||||
| Cash and short-term investments | $0.1M | $2.2M | $0.6M | $0.4M |
| Total debt | $3.5M | $2.4M | $3.1M | $2.6M |
| Finance lease liabilities | β | β | β | $1.8M |
| Current assets | $10.8M | $15.2M | $13.9M | $15.1M |
| Current liabilities | $9.4M | $11.4M | $10.6M | $11.2M |
| Inventory | $3.6M | $5.8M | $7.0M | $7.9M |
| Property and equipment, net | $11.6M | $11.1M | $11.7M | $9.2M |
| Intangible assets | β | $0.3M | β | β |
| Total assets | $22.5M | $26.5M | $26.0M | $24.3M |
| Total liabilities | $13.0M | $13.5M | $15.0M | $14.8M |
| Shareholders' equity | $9.5M | $13.1M | $11.0M | $9.5M |
| Margins | ||||
| Gross margin | 22.0% | 26.9% | 20.0% | 23.3% |
| Operating margin | β1.9% | 5.2% | β9.1% | β1.8% |
| EBITDA margin | 9.4% | 14.6% | 0.7% | 7.5% |
| Net margin | β1.6% | 6.7% | β8.7% | β6.4% |
| FCF margin | 2.5% | 3.0% | β7.7% | 0.1% |
| Returns | ||||
| Return on capital | β3.2% | 11.6% | β15.1% | β3.5% |
| Return on capital employed | β4.1% | 10.2% | β16.7% | β4.0% |
| Return on equity | β4.6% | 17.6% | β20.6% | β17.4% |
| Return on assets | β1.9% | 8.1% | β9.4% | β7.1% |
| Return on tangible equity | β4.6% | 15.5% | β22.5% | β18.8% |
| Growth | ||||
| Revenue growth | β | 5.8% | β3.4% | β1.3% |
| Net income growth | β | β | β225.5% | β |
| EPS growth | β | β | β216.7% | β |
| FCF growth | β | 26.8% | β350.6% | β |
| Share count change | β | 2.4% | 13.4% | 0.6% |
| Financial health | ||||
| Net debt / EBITDA | 1.3x | 0.1x | 13.1x | 1.9x |
| Debt / equity | 0.4x | 0.2x | 0.3x | 0.3x |
| Current ratio | 1.1x | 1.3x | 1.3x | 1.3x |
| Quick ratio | 0.8x | 0.8x | 0.7x | 0.6x |
| Capital allocation | ||||
| Capex / revenue | 4.5% | 6.5% | 4.4% | 2.3% |
| Stock comp / revenue | β | β | 1.6% | 1.1% |
| Quality scores | ||||
| Piotroski F-score | β | 7.0 | 1.0 | 7.0 |
| Altman Z'' | 2.3 | 3.7 | 2.0 | 2.5 |
| Accruals ratio | β10.5% | β3.3% | β5.8% | β9.8% |
Source: SEC EDGAR XBRL filings (CIK 0001866816). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.